510 related articles for article (PubMed ID: 7542353)
21. An overview of the cutaneous porphyrias.
Dawe R
F1000Res; 2017; 6():1906. PubMed ID: 29152226
[TBL] [Abstract][Full Text] [Related]
22. Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases.
Mathews-Roth MM; Pathak MA; Fitzpatrick TB; Harber LH; Kass EH
Arch Dermatol; 1977 Sep; 113(9):1229-32. PubMed ID: 900968
[TBL] [Abstract][Full Text] [Related]
23. The porphyrias: advances in diagnosis and treatment.
Balwani M; Desnick RJ
Blood; 2012 Nov; 120(23):4496-504. PubMed ID: 22791288
[TBL] [Abstract][Full Text] [Related]
24. [Porphyrias-what is verified?].
Stölzel U; Kubisch I; Stauch T
Internist (Berl); 2018 Dec; 59(12):1239-1248. PubMed ID: 30328490
[TBL] [Abstract][Full Text] [Related]
25. [Porphyrin fluorescence in plasma of various types of porphyria].
Gregor A; Kostrzewska E; Tarczyńska-Nosal S; Stachurska H
Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):284-6. PubMed ID: 7808953
[TBL] [Abstract][Full Text] [Related]
26. Porphyria cutanea tarda. New facts on aetiology, pathogenesis clinical manifestations and treatment.
Malina L; Chlumský J; Chlumská A
Acta Univ Carol Med Monogr; 1974; (59):1-126. PubMed ID: 4616623
[No Abstract] [Full Text] [Related]
27. [Diagnosis and therapy of hepatic porphyria].
Doss MO
Acta Med Austriaca; 1990; 17(5):94-9. PubMed ID: 2092571
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda.
Malina L; Chlumský J
Acta Derm Venereol; 1981; 61(4):346-50. PubMed ID: 6173993
[TBL] [Abstract][Full Text] [Related]
29. Porphyrias: A 2015 update.
Karim Z; Lyoumi S; Nicolas G; Deybach JC; Gouya L; Puy H
Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):412-25. PubMed ID: 26142871
[TBL] [Abstract][Full Text] [Related]
30. The porphyrias.
Sekula SA; Tschen JA; Rosen T
Am Fam Physician; 1986 Mar; 33(3):219-32. PubMed ID: 3513498
[TBL] [Abstract][Full Text] [Related]
31. [Porphyria cutanea tarda and chronic lymphatic leukemia].
Montag H; Schmeel A
Z Hautkr; 1984 Oct; 59(20):1372-6. PubMed ID: 6523956
[TBL] [Abstract][Full Text] [Related]
32. Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.
Felsher BF; Carpio NM; Engleking DW; Nunn AT
N Engl J Med; 1982 Apr; 306(13):766-9. PubMed ID: 7062951
[TBL] [Abstract][Full Text] [Related]
33. Newer aspects on the treatment of erythropoietic protoporphyria.
Sandberg S
Photodermatol; 1985 Feb; 2(1):1-2. PubMed ID: 3982990
[No Abstract] [Full Text] [Related]
34. Enzyme defects in hereditary porphyria.
Civin WH; Epstein E
Ann Clin Lab Sci; 1980; 10(5):395-401. PubMed ID: 6999973
[TBL] [Abstract][Full Text] [Related]
35. Update on the Porphyrias.
Dickey AK; Leaf RK; Balwani M
Annu Rev Med; 2024 Jan; 75():321-335. PubMed ID: 37540847
[TBL] [Abstract][Full Text] [Related]
36. [Combination therapy of porphyria cutanea tarda using chloroquine and bloodletting therapy].
Horkay I; Nagy E
Z Hautkr; 1980 Jun; 55(12):813-6. PubMed ID: 7415362
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of porphyria cutanea tarda by means of bloodletting].
Silny W
Przegl Dermatol; 1973; 60(3):397-401. PubMed ID: 4748082
[No Abstract] [Full Text] [Related]
38. Treatment of erythropoietic protoporphyria with beta-carotene.
Mathews-Roth MM
Photodermatol; 1984 Dec; 1(6):318-21. PubMed ID: 6533627
[TBL] [Abstract][Full Text] [Related]
39. [Variegata porphyria. Up to date concerning a recent case (author's transl)].
Gonday G; Imbert Y; Maire JP; Leng B
Sem Hop; 1981 Feb 18-25; 57(7-8):397-403. PubMed ID: 6261379
[TBL] [Abstract][Full Text] [Related]
40. [Experiences with iron elimination therapy in porphyria cutanea tarda].
Haneke E; Schwartze G
Z Gesamte Inn Med; 1971 Nov; 26(22):710-6. PubMed ID: 5141034
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
